Trial

ACTG 5306 Phase I Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin

Study Director
Start Date
6 / 2012
Trial Phase
Trial Status
enrolling
Current Enrollment
Target Enrollment
48
Overview
Compound Associations
Mycobacterial Gyrase Inhibitors